Serum levels of endostatin and VEGF in non-small cell lung cancer patients and the relationship with the clinical pathophysiological characteristics

Chinese Journal of Lung Cancer

Volumn 7, Issue 1, 2004, Pages 50-54

  Liu, Ying ^a   Zhou, Qinghua ^a   Lu, Yanrong ^a   Zhu, Wen ^a   Wang, Yanping ^a   Zhang, Jie ^a   Liu, Lunxu ^a   Sun, Zhilin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

ELISA; Endostatin; Lung neoplasm; VEGF

Indexed keywords

ENDOSTATIN; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; TUMOR VOLUME;

EID: 1342280626     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zhou QH. Advancements in surgical treatment of lung cancer. Chin J Lung Cancer, 1998, 1(1): 7-11.
2. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 1989, 246(4935): 1306-1309.
3. Wu Z, O'Reilly MS, Folkman J, et al. Suppression of tumor growth with recombinant murine angiostatin. Biochem Biophys Res Commun, 1997,236(3): 651-654.
4. Brooks PC, Montgomery AM, Cheresh DA. Use of the 10-day-old chick embryo model for studying angiogenesis. Methods Mol Biol, 1999,129: 257-269.
5. Kevin P, Clattey KP, Willcison WO, et al. Vascular endothelial growth factor. J Biol Chem, 1992,267(2): 16317-16322.
6. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88 (2): 277-285.
7. Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997,390(6658): 404-407.
8. Homer JJ, Greenman J, Stafford ND. Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcimona. Clin Otolaryngol, 2000,25(6): 570-576.
9. Strik HM, Schluesener HJ, Seid K, et al. Localization of endostatin in rat and human gliomas. Cancer, 2001,91(5): 1013-1019.
10. Liu Y, Zhou QH, Zhang SF, et al. Expression of endostatin and its relationship with the clinical pathophysiological characteristics in non-small cell lung cancer. Chin J Lung Cancer, 2002,5(6): 447-450.
11. Dong Z, Kumar R, Yang X, et al. Macrophage-derived metalloclastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 1997,88(6): 801-810.
12. Senger DR, Connolly DT, Van de Water L, et al. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res, 1990,50(6): 1774-1778.
13. Myoken Y, Kayada Y, Okamoto T, et al. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding siies. Proc Nail Acad Sci U S A, 1991,88(13): 5819-5823.
14. Houck KA, Ferrara N, Winer J, et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol, 1991,5(12): 1806-1814.
15. Giiay-Goren H, Soker S, Vlodavsky I, et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem, 1992,267 (9): 6093-6098.
16. Kuroi K, Tanaka C, Toi M. Circulating levels of endostatin in cancer patients. Oncol Rep 2001,8(2): 405-409.
17. Suzuki M, Iizasa T, Ko E, et al. Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer, 2002,35(1): 29-34.
18. Feldman AL, Pak H, Yang JC, et al. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer, 2001, 91(8): 1525-1529.
19. Feldman AL, Alexander HR Jr, Bartlett DL, et al. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann Surg Oncol, 2001,8(9): 741-745.
20. Feldman AL, Alexander HR Jr, Yang JC, et al. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer, 2002,95(8): 1637-1643.